MissionIR Articles
-
MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces IPO Closing
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of popular augmented reality interactive entertainment games and toys in China, today announced the July 30, 2019 closing of its underwritten initial public…
-
MissionIRNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Initiates First Phase of Branding Lead Drug Candidate
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced it has initiated the first phase of branding its lead drug candidate, Oncoprex(TM) immunogene therapy, and has completed and submitted non-proprietary drug name selections to…
-
Pressure BioSciences Inc.’s (PBIO) Entry into CBD Market Aims Next-Gen Nanoemulsification Platform at Critical Water-Solubility Issues
PBIO’s proprietary Ultra Shear Technology (UST) platform achieves the long sought-after ability to create truly water-soluble CBD oil that can provide optimized bioavailability CBD sales are projected to reach $89 billion by 2024 with a…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Summarizes DehydraTECH(TM) Technology Licensees
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today reported on its existing technology licensees that have entered definitive contracts to use its revolutionary DehydraTECH(TM) absorption technology within their existing…
-
MissionIRNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Posts Updated Terms to Spring Oaks Acquisition
Green Growth Brands (CSE: GGB) (OTCQB: GGBXF), a lifestyle-oriented cannabis company, on Monday announced an amendment to the share purchase agreement dated June 3, 2019 with Spring Oaks Greenhouses, Inc. Per the amended agreement, GGBXF…
-
MissionIRNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Increases Licensed Production Capacity
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, recently obtained approval from Health Canada for the licensing of all of the company’s Phase 4A buildout plans,…
-
Research Highlights Virtues of INmune Bio Inc.’s (NASDAQ: INMB) Strategy in Fighting Cancer with Body’s Own Natural Cells
California-based INmune Bio is developing therapies to battle cancers and Alzheimer’s disease by more effectively engaging the body’s own natural defenses Research published in a peer-reviewed scientific journal shows a mechanism by which scientists can…
-
MissionIRNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Upholds Commitment to Quality amid CBD Shortage
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, remains dedicated to maintaining its high standards in the midst of a growing cannabis supply gap. An article discussing the…
-
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) is “One to Watch”
China’s AR industry is estimated at RMB$55 billion in 2020 Favorable Chinese government policies emphasize research and development of new technologies such as AR Few direct competitors in China create exceptional potential for AR application…
-
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Announces Proprietary Nano-Emulsion Technology for Rapid-Onset of Cannabinoid Effects
Organigram’s proprietary nano-emulsion technology is expected to provide an initial onset of effects within 10 to 15 minutes for cannabis beverages The company’s shelf-stable, thermally stable, water-compatible and palatable cannabinoid nano-emulsion formulation allows for the…
-
MissionIRNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Gains Access to 60,000kg of CBD-rich Hemp through New Advance Purchase Agreement
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, this morning announced that it has entered into an advance payment and purchase agreement with 703454 N.B. Inc.…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces First Sale of the BaroShear K45, A Revolutionary Water-Soluble CBD Manufacturing System
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced the initial sale of its revolutionary BaroShear(TM)…
-
Earth Science Tech Inc. (ETST) Strengthens Foothold in Global CBD Arena
ETST subsidiary CTI is engaged in the research and development of cannabidiol The company has partnered with Canna Inno Laboratories Inc. to strengthen its foothold in the Canadian CBD market ETST’s Earth Science Pharma is…
-
MissionIRNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) to Present at 17th Annual Congress of International Drug Discovery Science & Technology 2019
INmune Bio (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, this morning announced that its Director of Neuroscience, C.J. Barnum, and Co-Founder and CEO,…
-
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Agreement Increases Reach of Ingested Cannabis Absorption Technology
Cannabis users have historically preferred to inhale smoke from the burned plant in order to achieve rapid-onset absorption of its properties, but Lexaria Bioscience is making it possible to achieve similar results through oral ingestion…
-
Earth Science Tech Inc. (ETST) Stock Evaluated by InvestorPlace Analyst
ETST stock recently caught the attention of InvestorPlace analyst Mark Putrino Putrino noted in an article that ETST stock stands out, because the company’s management team and advisory board exhibit impressive business experience ETST was…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Second Major Contract Utilizing its BaroFold Technology Platform
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced its entry into a contract services agreement…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Global Manufacturing & Licensing Partnership with Hill Street Beverage Co. (TSX.V: BEER)
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced a multi-faceted expansion of its relationship with Hill Street Beverage Company Inc. (TSX.V: BEER). According to the update, the companies…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Remains Ahead of the Pack with Innovative Delivery Technology
Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is the developer of the drug-delivery platform DehydraTECH(TM). The company’s innovative technology promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. An…
-
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Stands for Responsible Cannabis Use; Is the Industry Taking Adoption Too Far?
As the legal marijuana industry continues to rapidly expand, regulatory bodies in the U.S. and other parts of the world are facing lobby pressure to ensure widespread adoption Companies like Lexaria Bioscience have opposed such…
Search Articles
Latest Articles
- MissionIRNewsBreaks – XTI Aerospace, Inc. (NASDAQ: XTIA) Highlights Revenue Visibility and Operating Leverage at Shareholder Town Hall
- Safe Pro Group Inc. (NASDAQ: SPAI) Will Highlight the Company’s AI Capabilities for Military Engineers at Upcoming 2026 Defence Leaders Combat Engineer & Logistics Conference
- LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Aligns Liora and the LiGHT System With LB-100 to Push the Frontier of Cancer Treatment
- MissionIRNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Showcases DefendAir C-UAS Systems at Enforce Tac 2026 in Germany
- MissionIRNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment